PHARMA AND TECH +++++

PHARMA AND TECH ABC News: FDA Approves 1st Non-Antipsychotic Medication For Agitation In Alzheimer's Disease https://abcnews.com/Health/fda-approves-1st-antipsychotic-medication-agitation-alzheimers-disease/story?id=132583309&utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_L-m9csuzYJzDEr1V5yIdAFCGZZN7_cXGJWkNaMPG8PT3swrn9OGMv-6DRVaBOEgmfzKy6R7u_81Gk26D0N_tPC7aKdQ&_hsmi=417054630&utm_content=417054630&utm_source=hs_email The Food and Drug Administration (FDA) approved the drug Auvelity this week for the treatment of agitation in adults with Alzheimer's dementia. The extended-release tablet is the first FDA-approved medication for this condition that is not an anti-psychotic. Anti-psychotics carry serious risks including stroke, sedation and increased death in older adults, according to the FDA. Having a non-antipsychotic option may be safer for patients, experts say. (Miao and Joseph, 5/1) NBC News: AI Finds Signs Of Pancreatic Cancer Before Tumors Develop https://www.nbcnews.com/health/cancer/ai-early-signs-pancreatic-cancer-before-tumors-develop-rcna343099?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--QLdBba6pH1RPiMyqoVSDhT9R0GDVDkQkkB9u0Fy1FXX_-CJhS0qOyBBl3hpWzVIMMXyyBwEO5IltEkKOzosU7bwci9w&_hsmi=417054630&utm_content=417054630&utm_source=hs_email By the time doctors detect pancreatic cancer, it’s often too late to treat effectively. But a new study suggests that artificial intelligence might be able to find signs of the disease before tumors are visible on a scan. An AI model developed at the Mayo Clinic in Rochester, Minnesota, detected abnormalities on patients’ CT scans up to three years before they were diagnosed with pancreatic cancer, according to research published this week in the journal Gut. (Bendix, 5/2) CNBC: Weight Loss And Hair Loss: The Growing Market From GLP-1s https://www.cnbc.com/2026/05/02/hair-loss-glp-1s.html?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_vob3_dC-liL0CZxDy4JRZJ-5cp3Xc9kIbBP8smYLkrUwc_boAKPZCcwv7VBZ0Y0ENyCF6EqjlCZ-3EqoDWVLKdzKiOw&_hsmi=417054630&utm_content=417054630&utm_source=hs_email A common side effect of many GLP-1 drugs is hair loss. It's creating a formerly untapped but growing market for hair treatment products. (Neelakandan, 5/2) MedPage Today: Study Examines If Prenatal Exposure To Sedatives Is Linked To Psych Disorders https://www.medpagetoday.com/psychiatry/generalpsychiatry/121083?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--ntaOhwMiG5apCA57WY8zNHm3yyBu_EkA4dGijDXndiLH9991rPUU8LeD6IV15fzIEvxQSHPi4HI0z1aeh1aBxQXGkfQ&_hsmi=417054630&utm_content=417054630&utm_source=hs_email Prenatal exposure to sedative drugs used for anxiety and insomnia was not associated with an increased risk of psychiatric or neurodevelopmental conditions in children when accounting for familial factors, a large population-based cohort study from South Korea indicated. (Monaco, 5/1) The Washington Post: The Body’s Most Mysterious Organ May Play A Key Role In Longevity And Cancer https://www.washingtonpost.com/health/2026/05/03/thymus-longevity-cancer-research/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8RaGXU-jA3dDnRyOlMYlO1dOWCChAkPeg3VgdxlsJuuBSfanLRMPA1S9XKXmeZfXnkF1fBhlEwtd10ZOBpkx5QDH2aMA&_hsmi=417054630&utm_content=417054630&utm_source=hs_email A raft of research is recasting the thymus from a bit player to a potent regulator of aging and immune health. (Johnson, 5/3)